Cholesterol & Heart Health



Cholesterol Evil Trigger Heart Disease




Scientists have found new evidence related to the type of bad cholesterol more turns contributing to the occurrence of heart disease.

Unlike cholesterol low density lipoprotein cholesterol (LDL / low density lipoprotein cholesterol), which is widely known and unknown, Lipoprotein (a), or Lp (a) can not be controlled with diet to lose fat foods or taking statin drugs. However, the researchers argued the high levels of Lp (a) is lower risk than high LDL levels.


Other drugs are also believed to be working to minimize its effect. The study was published in the New England Journal of Medicine in its latest issue.



LDL known to be very aggressive in "attacking" the arteries and increases the risk of heart disease. Scientists believe that Lp (a) that are derived not "fierce" LDL cholesterol, but it can cause blood vessel blockage.

In examining the Lp (a), the researchers used a genetic chip technology to scan DNA that are potential points to the risk of heart disease that they know from previous studies.
Professor Martin Farrall, team members study conducted at Oxford University, Saturday (26/12), said that one in six people carries one or more genes Lp (a).

"Hopefully, by targeting therapy, for both LDL and Lp (a), we can find the best way to reduce the risk of heart disease better," said Martin Farrall.

He said the increased risk to individuals with high levels of Lp (a) was still lower than people with high LDL. The drugs that are present, such as niacin and other types that will enter the market as CETP-inhibitors reduce Lp (a), as well as LDL.


Professor Peter Weissberg of the British Heart Foundation said the findings are very useful because it emphasizes the importance of reducing levels of Lp (a) which will lead to new efforts. However, LDL cholesterol remains the primary type that must be considered. (BBC / INE)

Comments